Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Revenue

Percheron Therapeutics had revenue of 151.79K AUD in the half year ending December 31, 2024, a decrease of -69.24%. This brings the company's revenue in the last twelve months to 1.92M, down -28.14% year-over-year. In the fiscal year ending June 30, 2024, Percheron Therapeutics had annual revenue of 2.97M with 51.07% growth.

• Revenue (ttm): 1.92M
• Revenue Growth: -28.14%
• P/S Ratio: 5.10
• Revenue / Employee: 239.98K
• Employees: 8
• Market Cap: 9.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.97M	1.00M	51.07%
Jun 30, 2023	1.96M	186.87K	10.51%
Jun 30, 2022	1.78M	1.20M	207.72%
Jun 30, 2021	577.76K	-90.67K	-13.56%
Jun 30, 2020	668.43K	81.65K	13.91%